关于挑战菌株开发和GMP制造的监管研讨会 - 一次利益相关者会议报告
Nicoletta Corti1, Christopher Chiu2, Rebecca J Cox3
1European Vaccine Initiative (EVI), Heidelberg, Germany.
概括
一场研讨会讨论了用于控制人类感染模型 (CHIM) 研究的开发和制造挑战剂的挑战. 讨论重点是监管指南,GMP原则和促进安全和高质量的CHIM研究的伦理考虑.
科学领域:
- 监管科学是一种监管科学.
- 传染病研究传染病研究.
- 疫苗的研发工作正在进行中.
背景情况:
- 控制人类感染模型 (CHIM) 研究需要具有良好的特征的挑战剂.
- 开发人员面临的不确定性关于良好的制造实践 (GMP) 要求的挑战代理开发.
- 现有的指导是在2022年技术白皮书中提供的,当不能满足特定建议时,建议使用"良好生产规范原则".
研究的目的:
- 在IHI Inno4Vac CHIMICHURRI项目中组织一个监管研讨会.
- 为CHIM研究讨论挑战剂菌株的开发和制造.
- 解决监管不确定性,并为未来的CHIM研究提供指导.
主要方法:
- 召开了一个监管研讨会.
- 讨论涉及道德考虑,责任,临床终点,药剂选择和数据共享.
- 研讨会讨论了采购野生类型病毒分离物与逆转基因菌株的挑战.
主要成果:
- 在采购和描述野生型病毒分离物,包括转基因法规等方面发现了挑战.
- 强调需要为隔离采集提供官方知情同意指导方针.
- 针对针对疫苗反应和临床过程的人口异质性.
结论:
- 预计研讨会讨论将推动伦理,安全和高质量的CHIM研究.
- 建议将有助于建立流感,RSV和C. difficile CHIM研究的适当监管框架.
- 该倡议旨在改善开发和制造挑战剂的监管环境.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
In Vitro Drug Release Testing: Overview, Development and Validation
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...


